Posted: 25 July 2022 Breakthrough Victoria has announced recently its investment in Victorian medical technology group Seer Medical to support its plan to become a global leader in epilepsy home monitoring and management. Seer is globally renowned as…
Posted: 21 June 2022 The NHMRC has released a discussion paper presenting some options to reach gender equity in the Investigator Grant scheme. There will be a series of eight open forums held in Queensland, New South Wales,…
Posted: 19 July 2022 Melbourne, Australia: Neuren Pharmaceuticals (ASX: NEU) is pleased to report that its US partner Acadia Pharmaceuticals (Nasdaq: ACAD) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for…
Posted: July 18 2022 ANDHealth, Australia’s leading digital health commercialisation organisation, has announced the extension of its partnership with the Therapeutic Goods Administration (TGA) to support Australia’s fast-growing digital health sector. The extended partnership will see TGA fund…
Posted: 23 June 2022 Advertising compliance for therapeutic goods in Australia is complex, requiring one to remain up-to-date on a number of different advertising laws which are administered by different regulators. This article provides a timely reminder that as…
Posted: 16 June 2022 Key points: The first crop has been harvested from a medicinal cannabis facility built in a former fruit juice factory near Mildura Cann Group received approval to cultivate the crop at the $115 million…
Posted: 14 June 2022 Infectious disease experts gathered at the BioMelbourne Network BioForum today to share concerns regarding influenza (flu) preparedness, emerging public health challenges and vaccine innovation.1 According to data captured by the National Notifiable Disease…
Posted: 6 June 2022 Immutep reports positive Overall Response Rate in its Phase II clinical trial in 1st line NSCLC for PD-L1 all-comers TACTI-002 has met its primary objective for 1st line non-small cell lung cancer (NSCLC) patients…
Posted: 2 June 2022. I would firstly like to say thank you to our members, stakeholders and secretariat for such a warm welcome. It is in an honour and a privilege to lead the Committee for Melbourne into…
Date posted: 2 June 2022 Amplia has released new data showing that in a head-to-head preclinical comparison, using a mouse model of idiopathic pulmonary fibrosis (IPF), AMP945 showed comparable efficacy to the current standard of care. The current…
Posted: 31 May 2022 Written by – Denham Sadler National Affairs Editor InnovationAus.com Long-time tech and innovation advocate Ed Husic will be Australia’s new Industry Minister after he retained his spot in the new Labor government’s Cabinet, with Clare…
Posted: 30 May 2022 Avatar Brokers are proud to announce a significant milestone in the history of our company, with this month marking our 20th anniversary. Founded on May 29, 2002, Avatar Brokers began its operations after establishing…